A	O
tanshinone	B:C0075810
I	I:C0075810
derivative	O
enhances	O
the	O
activities	O
of	O
antibiotics	O
against	O
Staphylococcus	O
aureus	I:C0038172
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

A	O
tanshinone	O
I	I:C0075810
derivative	O
enhances	O
the	O
activities	B:C3714634
of	O
antibiotics	O
against	O
Staphylococcus	O
aureus	I:C0038172
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

A	O
tanshinone	O
I	I:C0075810
derivative	O
enhances	O
the	O
activities	O
of	O
antibiotics	B:C0003232
against	O
Staphylococcus	O
aureus	I:C0038172
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

A	O
tanshinone	O
I	I:C0075810
derivative	O
enhances	O
the	O
activities	O
of	O
antibiotics	O
against	O
Staphylococcus	B:C0038172
aureus	I:C0038172
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

A	O
tanshinone	O
I	I:C0075810
derivative	O
enhances	O
the	O
activities	O
of	O
antibiotics	O
against	O
Staphylococcus	O
aureus	I:C0038172
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

Infections	B:C3714514
caused	O
by	O
Staphylococcus	O
aureus	I:C0038172
are	O
prevalent	O
.	O

Infections	O
caused	O
by	O
Staphylococcus	B:C0038172
aureus	I:C0038172
are	O
prevalent	O
.	O

The	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	B:C0003232
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	O
bacteria	I:C1444090
,	O
represents	O
a	O
major	O
health	O
problem	O
in	O
both	O
hospital	O
and	O
community	O
settings	I:C1274109
.	O

The	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	O
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	B:C1444090
bacteria	I:C1444090
,	O
represents	O
a	O
major	O
health	O
problem	O
in	O
both	O
hospital	O
and	O
community	O
settings	I:C1274109
.	O

The	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	O
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	O
bacteria	I:C1444090
,	O
represents	O
a	O
major	O
health	O
problem	B:C0033213
in	O
both	O
hospital	O
and	O
community	O
settings	I:C1274109
.	O

The	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	O
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	O
bacteria	I:C1444090
,	O
represents	O
a	O
major	O
health	O
problem	O
in	O
both	O
hospital	B:C0019994
and	O
community	O
settings	I:C1274109
.	O

The	O
dramatically	O
reduced	O
discovery	O
of	O
new	O
antibiotics	O
,	O
as	O
well	O
as	O
the	O
persistent	O
emergence	O
of	O
resistant	O
bacteria	I:C1444090
,	O
represents	O
a	O
major	O
health	O
problem	O
in	O
both	O
hospital	O
and	O
community	B:C1274109
settings	I:C1274109
.	O

Using	O
antibiotic	B:C0003232
enhancers	O
to	O
rescue	O
existing	O
classes	O
of	O
antibiotics	O
is	O
an	O
attractive	O
strategy	O
.	O

Using	O
antibiotic	O
enhancers	O
to	O
rescue	O
existing	O
classes	O
of	O
antibiotics	B:C0003232
is	O
an	O
attractive	O
strategy	O
.	O

In	O
this	O
study	B:C2603343
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
(	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
)	O
was	O
synthesized	O
and	O
bacteriostatic	O
activity	I:C3714634
was	O
explored	O
.	O

In	O
this	O
study	O
,	O
16	B:C1254351
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
(	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
)	O
was	O
synthesized	O
and	O
bacteriostatic	O
activity	I:C3714634
was	O
explored	O
.	O

In	O
this	O
study	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
(	O
16	B:C1254351
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
)	O
was	O
synthesized	O
and	O
bacteriostatic	O
activity	I:C3714634
was	O
explored	O
.	O

In	O
this	O
study	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
(	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
)	O
was	O
synthesized	O
and	O
bacteriostatic	B:C3714634
activity	I:C3714634
was	O
explored	O
.	O

In	O
addition	O
,	O
synergistic	O
or	O
additive	O
activity	B:C3714634
between	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
and	O
aminoglycoside	O
antibiotics	I:C0003233
or	O
β-	O
lactam	I:C0026458
antibiotics	I:C0026458
in	O
vitro	O
was	O
identified	O
.	O

In	O
addition	O
,	O
synergistic	O
or	O
additive	O
activity	O
between	O
16	B:C1254351
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
and	O
aminoglycoside	O
antibiotics	I:C0003233
or	O
β-	O
lactam	I:C0026458
antibiotics	I:C0026458
in	O
vitro	O
was	O
identified	O
.	O

In	O
addition	O
,	O
synergistic	O
or	O
additive	O
activity	O
between	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
and	O
aminoglycoside	B:C0003233
antibiotics	I:C0003233
or	O
β-	O
lactam	I:C0026458
antibiotics	I:C0026458
in	O
vitro	O
was	O
identified	O
.	O

In	O
addition	O
,	O
synergistic	O
or	O
additive	O
activity	O
between	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
and	O
aminoglycoside	O
antibiotics	I:C0003233
or	O
β-	B:C0026458
lactam	I:C0026458
antibiotics	I:C0026458
in	O
vitro	O
was	O
identified	O
.	O

Moreover	O
,	O
16	B:C1254351
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	O
)	O
and	O
ampicillin	O
(	O
ampicillin	O
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	B:C0038425
(	O
streptomycin	O
)	O
and	O
ampicillin	O
(	O
ampicillin	O
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	B:C0038425
)	O
and	O
ampicillin	O
(	O
ampicillin	O
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	O
)	O
and	O
ampicillin	B:C0002680
(	O
ampicillin	O
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	O
)	O
and	O
ampicillin	O
(	O
ampicillin	B:C0002680
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	O
)	O
and	O
ampicillin	O
(	O
ampicillin	O
)	O
against	O
S.	B:C0038172
aureus	I:C0038172
in	O
a	O
murine	O
infection	I:C2986594
model	I:C2986594
.	O

Moreover	O
,	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
was	O
documented	O
to	O
augment	O
clearance	O
of	O
streptomycin	O
(	O
streptomycin	O
)	O
and	O
ampicillin	O
(	O
ampicillin	O
)	O
against	O
S.	O
aureus	I:C0038172
in	O
a	O
murine	B:C2986594
infection	I:C2986594
model	I:C2986594
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	B:C1254351
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	O
cell	O
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	O
of	O
antibiotics	O
inside	O
bacterial	O
cells	I:C0563199
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	B:C0004611
cell	O
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	O
of	O
antibiotics	O
inside	O
bacterial	O
cells	I:C0563199
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	O
cell	B:C3161472
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	O
of	O
antibiotics	O
inside	O
bacterial	O
cells	I:C0563199
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	O
cell	O
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	B:C4055506
of	O
antibiotics	O
inside	O
bacterial	O
cells	I:C0563199
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	O
cell	O
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	O
of	O
antibiotics	B:C0003232
inside	O
bacterial	O
cells	I:C0563199
.	O

Primary	O
mechanistic	O
insight	O
indicated	O
that	O
16	O
-	I:C1254351
aldehyde	I:C1254351
tanshinone	I:C1254351
I	I:C1254351
could	O
damage	O
the	O
bacterial	O
cell	O
membrane	I:C3161472
,	O
leading	O
to	O
accumulation	O
of	O
antibiotics	O
inside	O
bacterial	B:C0563199
cells	I:C0563199
.	O

This	O
finding	O
might	O
be	O
useful	O
for	O
treating	O
infections	B:C3714514
caused	O
by	O
S.	O
aureus	I:C0038172
and	O
expand	O
the	O
scope	O
of	O
application	O
of	O
tanshinones	O
.	O

This	O
finding	O
might	O
be	O
useful	O
for	O
treating	O
infections	O
caused	O
by	O
S.	B:C0038172
aureus	I:C0038172
and	O
expand	O
the	O
scope	O
of	O
application	O
of	O
tanshinones	O
.	O

This	O
finding	O
might	O
be	O
useful	O
for	O
treating	O
infections	O
caused	O
by	O
S.	O
aureus	I:C0038172
and	O
expand	O
the	O
scope	O
of	O
application	O
of	O
tanshinones	B:C0075810
.	O

